Trends and factors influencing long-acting contraceptive utilisation among contraceptive users in Ethiopia: repeated cross-sectional study.
Ethiopia
long-acting contraceptive
reproductive-age women
trends
utilisation
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
13 01 2021
13 01 2021
Historique:
entrez:
14
1
2021
pubmed:
15
1
2021
medline:
15
5
2021
Statut:
epublish
Résumé
Although nationally representative data are helpful in designing strategies and policies of programmes in a country, there is paucity of evidence with regard to trends and factors influencing utilisation of long-acting contraceptives (LACs). Thus, this study aimed to assess the trends and factors influencing LAC utilisation among contraceptive users in Ethiopia. A repeated cross-sectional study. The Performance Monitoring and Accountability (PMA2020) national community-based survey data were used, and 2035 contraceptive users participated. To identify trends, proportions of LAC users were analysed using PMA data from round 1 in January 2014 to round 6 in July 2018. Users using LAC methods or otherwise. There was a difference in trends in LAC utilisation in the last 4.5 years. There was a 7% increase in the proportion of implant users, while there were no significant changes in utilisation of intrauterine device and female sterilisation. Women in the middle wealth quintile were 1.7 times more likely than those in the lowest quintile to use LAC, while contraceptive users who received recommendations from healthcare providers as well as those who made decisions jointly with healthcare providers were more likely to use LAC compared with those who decided on their own. Women with access to their desired method of contraception were less likely to use LAC, while those informed about intrauterine contraceptive device were more likely to use LAC compared with their counterparts. Women served at health posts, private hospitals and others (family planning clinics, pharmacies and non-governmental organisations) were less likely to use LAC compared with women served at public hospitals. Overall the utilisation of LAC in Ethiopia is low. Therefore, much has to be done in terms of raising awareness about intrauterine device, how healthcare providers can help users in choosing contraceptive methods, and sharing of experiences between public hospitals and other family planning service delivery points.
Identifiants
pubmed: 33441349
pii: bmjopen-2020-037103
doi: 10.1136/bmjopen-2020-037103
pmc: PMC7812108
doi:
Substances chimiques
Contraceptive Agents
0
Contraceptive Agents, Female
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e037103Informations de copyright
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Reprod Health. 2014 Jul 03;11:51
pubmed: 24993034
Am J Obstet Gynecol. 2017 Feb;216(2):101-109
pubmed: 27662799
J Pregnancy. 2019 Jan 30;2019:2920491
pubmed: 30834145
BMC Womens Health. 2017 Apr 04;17(1):25
pubmed: 28376779
PLoS One. 2019 Jan 16;14(1):e0209602
pubmed: 30650085
Contraception. 2016 Jul;94(1):11-7
pubmed: 27018154
Pan Afr Med J. 2014 May 27;18:98
pubmed: 25404960
Popul Dev Rev. 2017 May;43(Suppl Suppl 1):166-191
pubmed: 29081552
Pan Afr Med J. 2015 Aug 06;21:246
pubmed: 26523185
PLoS One. 2015 Jun 19;10(6):e0130212
pubmed: 26091505
J Pediatr Adolesc Gynecol. 2016 Apr;29(2):104-10
pubmed: 26210293
BMC Public Health. 2016 Jan 16;16:44
pubmed: 26774918
Lancet Glob Health. 2019 Jul;7(7):e904-e911
pubmed: 31109881